Similar articles

• A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent.

  Tutwiler GF, Kirsch T, Bridi G. Tutwiler GF, et al. Diabetes. 1978 Aug;27(8):856-67. doi: 10.2337/diab.27.8.856. Diabetes. 1978. PMID: 98377
• Inhibition of intestinal calcium transport by antidiabetic biguanides.

  Wróbel J, Michalska L, Nagel G. Wróbel J, et al. Gen Pharmacol. 1979;10(3):269-73. doi: 10.1016/0306-3623(79)90100-9. Gen Pharmacol. 1979. PMID: 467964 No abstract available.
• [Comparison of the effects of phenformin, buformin and metformin on blood lactate level].

  Czyzyk A, Lao B, Bartosiewicz W, Szczepanik Z, Orłowska K. Czyzyk A, et al. Pol Arch Med Wewn. 1978 Mar;59(3):241-54. Pol Arch Med Wewn. 1978. PMID: 673874 Polish. No abstract available.
• Biguanides and lactate metabolism: a review.

  Hermann LS. Hermann LS. Dan Med Bull. 1973 Jun;20(3):65-79. Dan Med Bull. 1973. PMID: 4594325 Review. No abstract available.
• [Effects and adverse effects of antidiabetic derivatives of biguanide].

  Czyzyk A. Czyzyk A. Med Welt. 1975 Oct 17;26(42):1928-36. Med Welt. 1975. PMID: 1102836 Review. German. No abstract available.